Literature DB >> 182379

Cloned mouse mammary cell lines requiring androgens for growth in culture.

W J Desmond, S J Wolbers, G Sato.   

Abstract

Clonally derived cell lines have been established from the mouse mammary tumor Shionogi carcinoma 115. Physiological concentrations of androgens markedly increase the growth rate and saturation density of these clones. The cells fail to grow in 1% fetal bovine serum-supplemented medium, but addition of 10-50 nM androstanolone or testosterone results in resumption of exponential growth. Some other androgens, but not estrogens or progesterone, stimulate growth of these cells. Steroid receptors can be isolated from the cells. In addition to their effect on growth, androgens also cause a marked alteration in the cell and colony morphology of the clones.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182379     DOI: 10.1016/0092-8674(76)90188-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  10 in total

1.  Androgen regulation by the long terminal repeat of mouse mammary tumor virus.

Authors:  P Darbre; M Page; R J King
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

2.  Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells.

Authors:  W E Simon; M Hänsel; M Dietel; L Matthiesen; M Albrecht; F Hölzel
Journal:  In Vitro       Date:  1984-03

3.  Steroid-regulated growth of DDT1MF-2 cells is profoundly influenced by culture conditions.

Authors:  D J Lamb; M Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

4.  Proliferation of a highly androgen-sensitive ductus deferens cell line (DDT1MF-2) is regulated by glucocorticoids and modulated by growth on collagen.

Authors:  A J Syms; J S Norris; R G Smith
Journal:  In Vitro       Date:  1983-12

5.  Three cell lines showing androgen-dependent, -independent, and -suppressed phenotypes, established from a single tumor of androgen-dependent Shionogi carcinoma 115.

Authors:  T Yamaguchi; K Kawamoto; N Uchida; K Uchida; S Watanabe
Journal:  In Vitro Cell Dev Biol       Date:  1992-04

6.  Relapse of androgen-dependent tumour of mouse (Shionogi Carcinoma 115) after castration and oestrogen treatment.

Authors:  T Miyauchi; M Wakisaka; S Hara; O Matsuzaki; J Shimazaki
Journal:  Urol Res       Date:  1983

7.  Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice.

Authors:  N Uchida; K Yamaguchi; N Narita; K Nakao; Y Kitamura; K Matsumoto
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation.

Authors:  P Darbre; R J King
Journal:  J Cell Biol       Date:  1984-10       Impact factor: 10.539

9.  Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115).

Authors:  S Noguchi; Y Nishizawa; K Motomura; H Inaji; S Imaoka; H Koyama; K Matsumoto
Journal:  Jpn J Cancer Res       Date:  1993-06

10.  Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).

Authors:  M Q Fujita; T Yasui; B Sato; N Uchida; K Uchida; O Shiratori; K Takeda; K Matsumoto
Journal:  Jpn J Cancer Res       Date:  1992-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.